Diana Cantero

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype

B. Herránz, T. Cejalvo, A. Hernández-Laín, 2020, Cancers.

Immune profiling of gliomas reveals a connection with Tau function and the tumor vasculature

B. Herránz, T. Cejalvo, A. Hernández-Laín, 2020, bioRxiv.

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing

Juan F. García, J. Borrás, I. Salmon, 2018, Journal of neuropathology and experimental neurology.

Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab

G. De Velasco, A. Hernández-Laín, P. Sánchez-Gómez, 2019, Clinical and Translational Oncology.

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

M. Pajares, A. Hernández-Laín, P. Sánchez-Gómez, 2015, Molecular Cancer Therapeutics.

Temozolomide induces radiologic pseudoprogression and tumor cell vanishing in oligodendroglioma

A. Hernández-Laín, D. Cantero, J. Sepúlveda, 2016, Neurology.